Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Juvenile ankylosing spondylitis.

R Burgos-Vargas1, R E Petty

  • 1Rheumatology Unit, Hospital General de México, Mexico City.

Rheumatic Diseases Clinics of North America
|February 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Method for Producing Perfect Joints in Gum-Section Plates.

The Dental register·2021
Same author

Measuring impairments of functioning and health in patients with axial spondyloarthritis by using the ASAS Health Index and the Environmental Item Set: translation and cross-cultural adaptation into 15 languages.

RMD open·2016
Same author

Long-term outcome of anti-tumor necrosis factor alpha blockade in the treatment of juvenile spondyloarthritis.

Clinical and experimental rheumatology·2014
Same author

A decrease in galectin-1 (Gal-1) levels correlates with an increase in anti-Gal-1 antibodies at the synovial level in patients with rheumatoid arthritis.

Scandinavian journal of rheumatology·2012
Same author

Drug-drug interactions of non-steroidal anti-inflammatory drugs with other drugs in patients with rheumatic diseases.

Reumatologia clinica·2011
Same author

[The qualitative approach in health: an alternative to clinical research in rheumatic diseases].

Reumatologia clinica·2011
Same journal

Bridging the Divide in Global Rheumatology.

Rheumatic diseases clinics of North America·2026
Same journal

Foreword.

Rheumatic diseases clinics of North America·2026
Same journal

Pulmonary Complications of Biological Therapies in Inflammatory and Autoimmune Diseases.

Rheumatic diseases clinics of North America·2026
Same journal

Artificial Intelligence and Social Determinants of Health.

Rheumatic diseases clinics of North America·2026
Same journal

Updates in Ultrasound in Rheumatology.

Rheumatic diseases clinics of North America·2026
Same journal

Health Systems Strengthening to Promote Access to Care for Rheumatic and Musculoskeletal Diseases Globally.

Rheumatic diseases clinics of North America·2026
See all related articles

Early recognition of Juvenile Arthritis (JA) is possible through identifying children with SEA syndrome or chronic arthritis linked to HLA-B27. Further studies are needed to understand JA

Area of Science:

  • Pediatric rheumatology
  • Immunogenetics
  • Clinical medicine

Background:

  • Juvenile arthritis (JA) is a complex condition.
  • Understanding its clinical spectrum, associations with other spondyloarthropathies (SSA), and pathogenesis is evolving.
  • The role of HLA-B27 in chronic arthritis is recognized.

Purpose of the Study:

  • To highlight the potential for early recognition of JA.
  • To emphasize the need for comparative clinical studies on JA prevalence.
  • To suggest a review and development of diagnostic criteria for JA and adolescent spondyloarthritis (AS).

Main Methods:

  • Clinical data analysis for early recognition markers.
  • Identification of children with SEA syndrome or HLA-B27 associated arthritis.

Related Experiment Videos

  • Review of existing diagnostic criteria for Juvenile Rheumatoid Arthritis (JRA) and Ankylosing Spondylitis (AS).

    • Main Results:

    • Clinical data suggests early identification of JA is feasible.
    • SEA syndrome and HLA-B27 associated chronic arthritis are potential indicators for JA.
    • Current diagnostic criteria for JRA may require re-evaluation.

    Conclusions:

    • Early recognition of JA is achievable by identifying specific pediatric conditions and genetic markers.
    • Further research into immunogenetic, racial, and environmental factors is crucial for understanding JA pathogenesis.
    • Revised diagnostic criteria for JA and childhood/adolescent AS are warranted.